Top

Reactions Weekly

Published in:

01-01-2023 | Metastasis | Case report

Carboplatin/paclitaxel

Lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Schott S, et al. POTENTIAL APPROACH TO OVERCOME CHECKPOINT INHIBITOR RESISTANCE IN A LONG-TERM SURVIVOR PATIENT WITH RECURRENT ENDOMETRIAL CARCINOMA. International Journal of Gynecological Cancer 32 (Suppl. 2): A159, Oct 2022. Available from: URL: http://doi.org/10.1136/ijgc-2022-ESGO.339 [abstract]

Title: Carboplatin/paclitaxel
Lack of efficacy: case report
Publication date: 01-01-2023
Publisher: Springer International Publishing
Keywords: Metastasis
Salpingo-Oophorectomy
Endometrial Cancer
Endometrial Cancer
Lenvatinib
Letrozole
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-30508-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Carboplatin/paclitaxel

Lack of efficacy: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Amenamevir/pranoprofen

Remdesivir

Dasatinib/inotuzumab-ozogamicin/ruxolitinib

Alectinib

Alcohol/bicarbonate

Ceftriaxone/clindamycin/erythromycin